Switzerland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 21.87 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
2 |
USD 18.25 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
3 |
USD 1.82 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
4 |
USD 907.28 M
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
5 |
USD 857.00 M
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
6 |
USD 597.28 M
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
7 |
USD 364.54 M
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
8 |
USD 286.50 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
9 |
USD 244.17 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
10 |
USD 193.93 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
11 |
USD 179.33 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
12 |
USD 134.29 M
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
13 |
USD 132.06 M
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
14 |
USD 126.42 M
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
15 |
USD 94.04 M
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
16 |
USD 84.80 M
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
17 |
USD 59.56 M
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
18 |
USD 58.27 M
|
Dec. 31, 2023 | USD 14.90 | -4.42% |
|
Switzerland |
|
19 |
USD 51.94 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
20 |
USD 37.18 M
|
Dec. 31, 2023 | USD 4.52 | -0.71% |
|
Switzerland |
|
21 |
USD 29.33 M
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
22 |
USD 28.27 M
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
23 |
USD 27.75 M
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
24 |
USD 27.54 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
25 |
USD -11.80 M
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
26 |
USD -12.15 M
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
27 |
USD -12.36 M
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
28 |
USD -24.45 M
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
29 |
USD -54.11 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
30 |
USD -54.31 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
31 |
USD -61.56 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
32 |
USD -64.81 M
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
33 |
USD -70.69 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
34 |
USD -146.76 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
35 |
USD -202.70 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
The Health Care company in Switzerland with the highest EBITDA is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 21.87 B.
The Health Care company in Switzerland with the lowest EBITDA is CRISPR Therapeutics AG (NasdaqGM: CRSP) at USD -202.70 M.
The top 10 Health Care companies in Switzerland by EBITDA are Roche Holding AG, Novartis AG, Lonza Group AG, DSM-Firmenich AG, Sandoz Group AG, Straumann Holding AG, Galenica AG, Siegfried Holding AG, Tecan Group AG and Bachem Holding AG.
The bottom 10 Health Care companies in Switzerland by EBITDA are CRISPR Therapeutics AG, ADC Therapeutics SA, Molecular Partners AG, DocMorris AG, AC Immune SA, Oculis Holding AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, Kuros Biosciences AG and Addex Therapeutics Ltd.